Growth Factor Treatment Reduces Arrhythmia Risk in Heart Repair
Author Information
Author(s): Bocchi Leonardo, Savi Monia, Graiani Gallia, Rossi Stefano, Agnetti Aldo, Stillitano Francesca, Lagrasta Costanza, Baruffi Silvana, Berni Roberta, Frati Caterina, Vassalle Mario, Squarcia Umberto, Cerbai Elisabetta, Macchi Emilio, Stilli Donatella, Quaini Federico, Musso Ezio
Primary Institution: Università di Parma, Parma, Italy
Hypothesis
Mobilization of cardiac progenitor cells through locally delivered growth factors can lower the risk of arrhythmias in a rat model of chronic myocardial infarction.
Conclusion
Local injection of growth factors improves heart function and reduces the occurrence of arrhythmias in rats with chronic myocardial infarction.
Supporting Evidence
- Growth factors decreased stress-induced arrhythmias in treated rats.
- Effective refractory period was prolonged in the growth factor treated group.
- New myocardial tissue was formed in the infarcted area after treatment.
- Markers of cardiac hypertrophy and fibrosis were reduced in treated rats.
- Improved intercellular coupling was observed with increased connexin43 expression.
Takeaway
Giving special proteins to help heart cells can make the heart work better and stop it from having dangerous heartbeats.
Methodology
The study involved 133 adult male Wistar rats, which were treated with growth factors or vehicle after inducing myocardial infarction, and various cardiac functions were measured.
Limitations
The study was conducted in a rat model, which may not fully replicate human heart conditions.
Participant Demographics
Adult male Wistar rats, aged 12–14 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website